Michael Wakelam
 | This article needs additional citations for verification. (April 2020) |
Michael Wakelam | |
|---|---|
| Born | 1955 |
| Died | 31 March 2020 |
| Nationality | British |
| Scientific career | |
| Fields | biochemistry, lipidomics, signal transduction |
| Institutions | Babraham Institute |
Michael John Owen Wakelam (15 July 1955 – 31 March 2020) was a British
molecular biologist and director of the Babraham Institute in Cambridge
, England.
Biography
Wakelam received a BSc in medical
Senior Lecturer (1991) and Reader (1992). He became a Professor of molecular pharmacology at the University of Birmingham in 1993. In 2007, he became director of the Babraham Institute in Cambridge.[1]
Wakelam died on 31 March 2020, of a suspected COVID-19 infection during the COVID-19 pandemic in England.[2]
References
- ^ "Michael Wakelam 1955 – 2020 | Babraham Institute". www.babraham.ac.uk. Retrieved 2 April 2020.
- ^ Babraham Institute director Professor Michael Wakelam dies after suspected coronavirus infection
External links
- Michael Wakelam's group Archived 17 June 2020 at the Wayback Machine at the Babraham Institute
| International | |
|---|---|
| National | |
| Academics | |
| Other | |
 | This article about a biologist from the United Kingdom is a stub. You can help Wikipedia by expanding it. |